Cytra-2 label

Cytra-2

Cytra-2 Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

CYTRA-2 Oral Solution is an effective alkalinizing agent.  It is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated.  This product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively.

CYTRA-2 Oral Solution is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose.  This product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage.  This product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods.

History

There is currently no drug history available for this drug.

Other Information

Oral Solution
Rx Only
NDC 60258-001-16

DESCRIPTION

CYTRA-2 Oral Solution is a stable and pleasant-tasting systemic alkalizer containing sodium citrate and citric acid in a sugar-free base.  It is a nonparticulate neutralizing buffer.

CYTRA-2 contains in each teaspoonful (5 mL):

Sodium Citrate Dihydrate………………….500 mg

Citric Acid Monohydrate…………………..334 mg

Each mL contains 1 mEq Sodium Ion, and is equivalent to 1 mEq Bicarbonate (HC0
3).

Cytra-2 Manufacturers

  • Cypress Pharmaceutical, Inc.
    Cytra-2 | Cypress Pharmaceutical, Inc.
    No Recall

    Cytra-2 | Cypress Pharmaceutical, Inc.

    Cytra-2 | Cypress Pharmaceutical, Inc.
    CYTRA-2 Oral Solution should be administered by diluting in water, followed by additional water, if desired.  SHAKE WELL BEFORE USING.

    For Systemic Alkalization:
    Usual Adult Dosage:  2 to 6 teaspoonfuls (10 to 30 mL), diluted in 1 to 3 ounces of water, after meals and at bedtime, or as directed by a physician.

    Usual Pediatric Dose:  1  to 3 teaspoonfuls (5 to 15 mL), diluted in 1 to 3 ounces of water, after meals and at bedtime, or as directed by a physician.  For children under two years of age, use is based on consultation with a physician.

    As a neutralizing buffer:  3 teaspoonfuls (15 mL), diluted with 15 mL water, taken as a single dose, or as directed by a physician.